Is IOBCF or XYLD a better dividend investment in 2026?

IOBCF currently yields 1.84% with a 5% 5-year dividend growth rate. XYLD yields 10.98% with 0.5% growth. The better choice depends on your goal: XYLD offers higher current income.

What is the dividend yield difference between IOBCF and XYLD?

IOBCF has a forward dividend yield of 1.84% ($0.28/share annually). XYLD yields 10.98% ($4.30/share annually). The yield gap is 9.14 percentage points.

Home › Compare › IOBCF vs XYLD

IOBCF vs XYLD: Dividend Comparison 2026

IOBCF yields 1.84% · XYLD yields 10.98%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 IOBCF wins by $45.32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

IOBCF

● Live price

1.84%

Share price

$15.00

Annual div

$0.28

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.35M

Annual income

$41,068,608.41

Full IOBCF calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

10.98%

Share price

$39.13

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.3K

Annual income

$3,219.02

Full XYLD calculator →

Portfolio growth — IOBCF vs XYLD

📍 IOBCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	IOBCF	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, IOBCF + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

IOBCF pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IOBCF

Annual income on $10K today (after 15% tax)

$156.68/yr

After 10yr DRIP, annual income (after tax)

$34,908,317.15/yr

XYLD

Annual income on $10K today (after 15% tax)

$933.63/yr

After 10yr DRIP, annual income (after tax)

$2,736.17/yr

At 15% tax rate, IOBCF beats the other by $34,905,580.98/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IOBCF + XYLD for your $10,000?

IOBCF: 50%XYLD: 50%

100% XYLD50/50100% IOBCF

Portfolio after 10yr

$22.69M

Annual income

$20,535,913.72/yr

Blended yield

90.52%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IOBCF buys

XYLD buys

No recent congressional trades found for IOBCF or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricIOBCFXYLD

Forward yield	1.84%	10.98% ✓
Annual dividend / share	$0.28	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$45.35M ✓	$25.3K
Annual income after 10y	$41,068,608.41 ✓	$3,219.02
Total dividends collected	$44.99M ✓	$19.6K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: IOBCF vs XYLD ($10,000, DRIP)

Year	IOBCF Portfolio	IOBCF Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$11,069	$368.67	$10,818	$1,098.39	+$251.00 → IOBCF
2	$12,606	$762.74	$11,738	$1,222.51	+$868.00 → IOBCF
3	$15,112	$1,623.72	$12,774	$1,364.64	+$2.3K → IOBCF
4	$19,809	$3,638.35	$13,944	$1,527.86	+$5.9K → IOBCF
5	$30,109	$8,913.99	$15,270	$1,715.87	+$14.8K → IOBCF
6	$57,543	$25,325.84	$16,775	$1,933.09	+$40.8K → IOBCF
7	$152,040	$90,469.27	$18,490	$2,184.87	+$133.6K → IOBCF
8	$609,485	$446,801.92	$20,450	$2,477.63	+$589.0K → IOBCF
9	$4,000,001	$3,347,852.94	$22,697	$2,819.19	+$3.98M → IOBCF
10	$45,348,610	$41,068,608.41	$25,280	$3,219.02	+$45.32M → IOBCF

IOBCF vs XYLD: Complete Analysis 2026

IOBCF — Stock

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for advance research in ConformalFLASH. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

Full IOBCF Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this IOBCF vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IOBCF vs SCHD IOBCF vs JEPI IOBCF vs O IOBCF vs KO IOBCF vs MAIN IOBCF vs QYLD IOBCF vs JEPQ IOBCF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.